Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |